< Back to previous page
Researcher
Abhishek Garg
- Disciplines:Adaptive immunology, Applied immunology, Innate immunity, Inflammation, Cancer biology, Cancer therapy
Affiliations
- Laboratory of Cell Stress & Immunity (Division)
Responsible
From1 Feb 2020 → Today - Laboratory of Cell Stress & Immunity (Division)
Member
From1 Mar 2020 → Today - Laboratory of Cell Death Research & Therapy (VIB-KU Leuven) (Division)
Member
From30 Oct 2008 → 29 Feb 2020
Projects
1 - 10 of 34
- Next generation immunotherapy solutions against macrophages to overcome cancer immuno-resistanceFrom1 Mar 2024 → TodayFunding: IOF - technology validation in lab
- Revealing the cancer cell-intrinsic immunotherapy targets in glioblastoma using reverse translational approachesFrom9 Jan 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatially resolved radio-multiomicsFrom1 Jan 2024 → TodayFunding: HORIZON.2.1 - Health
- Revealing the cancer cell-intrinsic immunotherapy targets in glioblastoma using reverse translational approaches.From11 Oct 2023 → TodayFunding: BOF - postdoctoral mandates
- A multimodel approach to define conserved immune landscapes behind clinical responses to immune checkpoint blockers in gastrointestinal tumours.From1 Oct 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Immunotherapy for childhood, adolescent, and adult Glioblastoma: towards tumour-immune interactions driven precision medicine using spatially resolved radio-multiomics.From15 Jan 2023 → TodayFunding: BOF - various
- Towards reverse translational investigation of cancer cell-intrinsic immunotherapy targets in glioblastomaFrom3 Jan 2023 → 28 Jul 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Unique IsoPlexis technology for multiplexed single cell functional profilingFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Building a proprietary platform for DNA-antibody based therapeuticsFrom1 Oct 2022 → TodayFunding: IOF - technology validation in lab
- Deep multi-omics dissection of the CD8+T-cell immune-landscape in colorectal cancer (CRC) to reveal tumor-specific vs. microbial immune- drivers for immuno-oncological applicationFrom1 Oct 2022 → 28 Apr 2023Funding: FWO senior postdoctoral fellowship
Publications
101 - 110 of 139
- Melanoma immunotherapy(2015)
Authors: Abhishek Garg, Patrizia Agostinis
Pages: 845 - 6 - Autophagy induced by Photodynamic Therapy (PDT): Shaping resistance against cell death and anti-tumour immunity(2015)
Authors: Abhishek Garg, Patrizia Agostinis
Pages: 99 - 116 - Targeting the hallmarks of cancer with therapy-induced endoplasmic reticulum (ER) stress(2015)
Authors: Abhishek Garg, Hannelore Maes, Alex van Vliet, Patrizia Agostinis
Pages: e975089 - Classification of current anticancer immunotherapies(2014)
Authors: Patrizia Agostinis, Abhishek Garg
Pages: 12472 - 12508 - Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy(2014)
Authors: Abhishek Garg, Patrizia Agostinis
- NEWCASTLE DISEASE VIROTHERAPY, A NOVEL IMMUNOTHERAPEUTIC APPROACH FOR HIGH GRADE GLIOMA(2014)
Authors: Carolien Koks, Abhishek Garg, Michael Ehrhardt, Matteo Riva, Steven De Vleeschouwer, Patrizia Agostinis, Norbert Graf, Stefaan Van Gool, Stefaan Van Gool
Pages: 40 - 40 - ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses(2014)
Authors: Abhishek Garg, Patrizia Agostinis
Pages: 474 - 87 - BNIP3 supports melanoma cell migration and vasculogenic mimicry by orchestrating the actin cytoskeleton(2014)
Authors: Hannelore Maes, Kris Nys, Abhishek Garg, Tom Verfaillie, Patrizia Agostinis
- Danger signalling during cancer cell death: origins, plasticity and regulation(2014)
Authors: Abhishek Garg, Shaun Martin, Patrizia Agostinis
Pages: 26 - 38 - Autophagy: shaping the tumor microenvironment and therapeutic response(2014)
Authors: Abhishek Garg, Patrizia Agostinis
Pages: 130 - 148
Patents
1 - 1 of 1